ArticlebioRxiv : the preprint server for biology2025
PIAS1/PIAS4-Mediated SUMOylation of TDP-43 Is Induced by Oxidative Stress.
Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- E3 ubiquitin ligases: structural diversity, dysregulation in disease, and their emerging role in targeted therapeutic strategies.Frontiers in molecular biosciences · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
TAR DNA-binding protein 43 (TDP-43) is a conserved RNA and DNA binding protein that functions in transcriptional repression, pre-mRNA splicing and mRNA stabilization. Under pathological conditions found in multiple neurodegenerative diseases, TDP-43 shows aberrant mislocalization from the nucleus and cytoplasmic accumulation and aggregation. TDP-43 also appears to play a role in DNA damage repair, specifically in non-homologous end-joining (NHEJ), suggesting that nuclear depletion of TDP-43 may contribute towards the accumulation of DNA damage observed in TDP-43 proteinopathies. These TDP-43 pathological inclusions are decorated with post-translational modifications, most notably phosphorylation. SUMOylation (Small Ubiquitin-like Modifier) is a dynamic post-translational modification that regulates many protein properties and is implicated in neurodegenerative disease pathology. DNA damage repair proteins are commonly regulated through SUMOylation, and the SUMO E3 ligases PIAS1 and PIAS4 are required for efficient DNA repair of double-strand DNA breaks. Given these findings, we investigated TDP-43 SUMOylation and whether SUMO modification impacts TDP-43's DNA damage repair function. We show that TDP-43 can be modified by SUMO1 and SUMO2/3 and confirm SUMOylation in response to oxidative stress. We also determine which regions of TDP-43 are SUMOylated and show that this modification is facilitated by the SUMO E3 ligases PIAS1 and PIAS4. Etoposide-induced DNA damage did not promote SUMOylation of TDP-43; studies are ongoing to determine the impact of TDP-43 SUMOylation on DNA repair.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.